CaP CURE: Association for the Cure of Cancer of the Prostate.

IF 6.3 2区 医学 Q1 ONCOLOGY Neoplasia Pub Date : 2002-01-01 DOI:10.4135/9781412953979.n49
Claudia Winograd
{"title":"CaP CURE: Association for the Cure of Cancer of the Prostate.","authors":"Claudia Winograd","doi":"10.4135/9781412953979.n49","DOIUrl":null,"url":null,"abstract":"Prostate Cancer Prostate cancer is the second leading cause of cancer death in men. In 2002, an estimated 189,000 men will be diagnosed with prostate cancer and almost 30,000 men will lose their lives to the disease. Prostate cancer frequently causes few, if any, symptoms in its early stages. Yet, prostate cancer is the most commonly occurring non–skin cancer in men, affecting one man in every six during his lifetime. More men will be at risk as the 76 million members of the baby boom generation continue to age.","PeriodicalId":48716,"journal":{"name":"Neoplasia","volume":"20 1","pages":"369-71"},"PeriodicalIF":6.3000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neoplasia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4135/9781412953979.n49","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Prostate Cancer Prostate cancer is the second leading cause of cancer death in men. In 2002, an estimated 189,000 men will be diagnosed with prostate cancer and almost 30,000 men will lose their lives to the disease. Prostate cancer frequently causes few, if any, symptoms in its early stages. Yet, prostate cancer is the most commonly occurring non–skin cancer in men, affecting one man in every six during his lifetime. More men will be at risk as the 76 million members of the baby boom generation continue to age.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
CaP CURE:前列腺癌治疗协会。
前列腺癌是男性癌症死亡的第二大原因。2002年,估计有18.9万名男子被诊断患有前列腺癌,近3万名男子将死于这种疾病。前列腺癌的早期症状很少,如果有的话。然而,前列腺癌是男性中最常见的非皮肤癌,一生中每六个人中就有一个受其影响。随着7600万婴儿潮一代的年龄继续增长,更多的男性将面临这种风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neoplasia
Neoplasia ONCOLOGY-
自引率
2.10%
发文量
82
期刊介绍: Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.
期刊最新文献
Non-redundant roles of the CCR1 and CCR2 chemokine axes in monocyte recruitment during lung metastasis. Sequential treatment of anti-PD-L1 therapy prior to anti-VEGFR2 therapy contributes to more significant clinical benefits in non-small cell lung cancer. DCZ0014, a novel compound in the therapy of diffuse large B-cell lymphoma via the B cell receptor signaling pathway. Corrigendum to "Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile." Neoplasia 2009, Feb;11(2):167-176. The dual PI3K/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1